AstraZeneca: 3 billion dollar bond to refinance debt
(CercleFinance.com) - AstraZeneca is making a four tranche global bond offering totalling 3 billion dollars for the refinancing of its existing debt, the drugmaker said on Wednesday.
The transaction consists of an 850 million dollar tranche of fixed rate notes with a coupon of 3.5% maturing in 2023; 400 million dollars of floating rate notes with a coupon of 3 month LIBOR plus 0.665%, maturing in 2023; 1 billion dollars of fixed rate notes with a coupon of 4%, maturing in 2029 and 750 million dollars of fixed rate notes with a coupon of 4.375%, maturing in 2048, the company said.
Shares of AstraZeneca were broadly flat this morning on the London Stock Exchange.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The transaction consists of an 850 million dollar tranche of fixed rate notes with a coupon of 3.5% maturing in 2023; 400 million dollars of floating rate notes with a coupon of 3 month LIBOR plus 0.665%, maturing in 2023; 1 billion dollars of fixed rate notes with a coupon of 4%, maturing in 2029 and 750 million dollars of fixed rate notes with a coupon of 4.375%, maturing in 2048, the company said.
Shares of AstraZeneca were broadly flat this morning on the London Stock Exchange.
Copyright (c) 2018 CercleFinance.com. All rights reserved.